Drug intelligence / Profile preview

manna

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Manna is a natural medicinal substance consisting of the dried saccharine exudate obtained from the trunk of the manna ash, *Fraxinus ornus*. Its primary active constituent is mannitol, a sugar alcohol (polyol) that typically comprises 40% to 90% of the exudate's mass, alongside other sugars such as glucose, fructose, and oligosaccharides like mannotetrose. Manna has historically been employed as a mild osmotic laxative and a sweetener for diabetic patients. Its pharmacological action is primarily attributed to the osmotic properties of mannitol; when ingested, it remains largely unabsorbed in the gastrointestinal tract, creating an osmotic gradient that draws water into the intestinal lumen. This increase in intraluminal pressure and fluid volume promotes bowel motility and facilitates evacuation. Although its use in mainstream medicine has largely been replaced by purified mannitol and other synthetic osmotic agents, it remains a recognized natural product in various pharmacopeias and is still utilized in certain traditional and herbal medicinal preparations, particularly for pediatric constipation.

Brand names
Manna
Other names
Fraxinus ornus exudateManna ash exudateManna sugar

Beyond the preview

Go deeper on manna.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on manna.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call